The US-based companies have jointly produced the experimental oral antiviral drug, which was originally developed to treat flu. At a press briefing on Tuesday afternoon, DGDA Director General Maj Gen Mahbubur Rahman said that the DGDA gave authorization to Beximco and Eskayef while eight others were waiting. According to the DGDA, Beximco Pharmaceuticals got the approval on Monday and Eskayef Pharmaceuticals Ltd on Tuesday. Beximco in a statement said it began production of a generic version of the medicine on Tuesday. This is the first oral antiviral treatment for Covid-19 to get approved, with the green light coming ahead of potential US regulatory clearance.

Source: Dhaka Tribune November 09, 2021 18:03 UTC